An Alzheimer’s drug is on the way, but getting it may still be tough. Here’s why
(By Jon Hamilton for NPR) The first drug shown to slow down Alzheimer’s disease is likely to receive full approval
Read More(By Jon Hamilton for NPR) The first drug shown to slow down Alzheimer’s disease is likely to receive full approval
Read More(Source – www.cms.gov) The Centers for Medicare & Medicaid Services (CMS) is committed to fostering innovation while ensuring that people
Read More(By Andrew Cass for Becker’s Hospital Review) More than 230 U.S. representatives and 61 senators are asking HHS and CMS
Read More(By Rylee Wilson for Becker’s Hospital Review) CMS is projecting a 7.7 percent increase in private health insurance spending in
Read More(Source – cms.gov/newsroom) A continuing key priority of the Biden-Harris Administration is lowering prescription drug costs. Today, the Department of
Read More(By Rylee Wilson for Becker’s Hospital Review) New GLP-1 drugs to treat diabetes and obesity can be expensive, and most
Read More(Source – The Kaiser Family Foundation Published June 2023) Medicare provides health insurance coverage for more than 65 million people,
Read More(By Riz Hatton for Becker’s Hospital Review) Sixty-five percent of physicians plan to continue treating Medicare and Medicaid patients, according
Read More(By Erica Carbajal for Becker’s Hospital Review) Newly released data from the CDC shows more than 9 million U.S. adults
Read More(By Kerry Dooley Young for STAT) For years, patients and medical groups have advocated for Medicare to cover wheelchairs with
Read More